| REVIEW ARTICLE |
|
| Year : 2019 | Volume
: 5
| Issue : 4 | Page : 160-168 |
|
|
Selection of preclinical models to evaluate intranasal brain cooling for acute ischemic stroke
Yining Chen1, Ayesha Quddusi1, Kathleen A Harrison1, Paige E Ryan1, Douglas J Cook2
1 Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada
2 Centre for Neuroscience Studies, Queen's University; Department of Surgery, Division of Neurosurgery, Kingston General Hospital, Kingston, ON, Canada
Correspondence Address:
Dr. Douglas J Cook
Centre for Neuroscience Studies, Queen's University, Room 232, 18 Stuart Street, Kingston, ON K7L3N6
Canada
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/bc.bc_20_19
|
|
|
Stroke accounts for a large proportion of global mortality and morbidity. Selective hypothermia, via intranasal cooling devices, is a promising intervention in acute ischemic stroke. However, prior to large clinical trials, preclinical studies in large animal models of ischemic stroke are needed to assess the efficacy, safety, and feasibility of intranasal cooling for selective hypothermia as a neuroprotective strategy. Here, we review the available scientific literature for evidence supporting selective hypothermia and make recommendations of a preclinical, large, animal-based, ischemic stroke model that has the greatest potential for evaluating intranasal cooling for selective hypothermia and neuroprotection. We conclude that among large animal models of focal ischemic stroke including pigs, sheep, dogs, and nonhuman primates (NHPs), cynomolgus macaques have nasal anatomy, nasal vasculature, neuroanatomy, and cerebrovasculature that are most similar to those of humans. Moreover, middle cerebral artery stroke in cynomolgus macaques produces functional and behavioral deficits that are quantifiable to a greater degree of precision and detail than those that can be revealed through available assessments for other large animals. These NHPs are also amenable to extensive neuroimaging studies as a means of monitoring stroke evolution and evaluating infarct size. Hence, we suggest that cynomolgus macaques are best suited to assess the safety and efficacy of intranasal selective hypothermia through an evaluation of hyperacute diffusion-weighted imaging and subsequent investigation of chronic functional recovery, prior to randomized clinical trials in humans.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
